SPECTA: Screening Cancer Patients for Efficient Clinical Trial Access
SPECTA: Screening Cancer Patients for Efficient Clinical Trial Access
SPECTA is a quality assured platform for collecting clinicopathologically annotated biological material, imaging data, operative images, environmental assessment, questionnaires as well as patient-reported outcomes from cancer patients to support biospecimen-based translational research and clinical cancer research, including biomarker discovery to improve the understanding of tumor biology and cancer patients care.
Patients are recruited in the platform for the research purpose of 5 downstream projects. For more information, please have a look at the "Groups and cohorts" section.
specta@eortc.org+32 2 774 1611
Bordeaux, 33075, France
Saint-Herblain, 44805, France
Greifswald, 17475, Germany
Bologna, 40138, Italy
Genova, 16132, Italy
Torino, 10126, Italy
Torino, 10126, Italy
Torino, 10126, Italy
Amsterdam, 1066 CX, Netherlands
Lisbon, 1099-023 CODEX, Portugal
Lisbon, 1449-005, Portugal
L'Hospitalet de Llobregat, Barcelona 08908, Spain
Girona, 17007, Spain
L'Hospitalet de Llobregat, 08907, Spain
Bodelwyddan, Denbighshire LL18 5UJ, United Kingdom
Birmingham, B15 2TH, United Kingdom
Cambridge, CB2 0QQ, United Kingdom
Coventry, CV2 2DX, United Kingdom
Glasgow, G12 OYN, United Kingdom
Leeds, LS9 7TF, United Kingdom
Liverpool, L7, United Kingdom